IMC Chicago’s ProShares UltraShort Health Care RXD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $650K | Sell |
9,250
-11,100
| -55% | -$204K | ﹤0.01% | 3750 |
|
|
2025
Q4 | $1.42M | Buy |
20,350
+4,150
| +26% | +$81.5K | ﹤0.01% | 2701 |
|
|
2025
Q3 | $1.09M | Sell |
16,200
-49,050
| -75% | -$1.18M | ﹤0.01% | 2646 |
|
|
2025
Q2 | $4.58M | Buy |
65,250
+32,900
| +102% | +$804K | ﹤0.01% | 1442 |
|
|
2025
Q1 | $2.18M | Buy |
32,350
+8,850
| +38% | +$190K | ﹤0.01% | 1747 |
|
|
2024
Q4 | $1.72M | Sell |
23,500
-92,150
| -80% | -$1.96M | ﹤0.01% | 1977 |
|
|
2024
Q3 | $3.88M | Buy |
115,650
+53,750
| +87% | +$1.06M | ﹤0.01% | 1256 |
|
|
2024
Q2 | $3.31M | Sell |
61,900
-85,100
| -58% | -$1.87M | ﹤0.01% | 1270 |
|
|
2024
Q1 | $3.82M | Sell |
147,000
-1,950
| -1% | -$42.5K | ﹤0.01% | 1073 |
|
|
2023
Q4 | $5.69M | Sell |
148,950
-3,300
| -2% | -$87K | ﹤0.01% | 841 |
|
|
2023
Q3 | $7.28M | Buy |
152,250
+21,700
| +17% | +$544K | 0.01% | 645 |
|
|
2023
Q2 | $5.05M | Sell |
130,550
-126,300
| -49% | -$3.2M | ﹤0.01% | 674 |
|
|
2023
Q1 | $8.82M | Sell |
256,850
-700
| -0.3% | -$18K | 0.01% | 522 |
|
|
2022
Q4 | $12.8M | Buy |
257,550
+31,050
| +14% | +$789K | 0.02% | 408 |
|
|
2022
Q3 | $12.7M | Sell |
226,500
-800
| -0.4% | -$21.6K | 0.02% | 391 |
|
|
2022
Q2 | $10.9M | Sell |
227,300
-14,200
| -6% | -$386K | 0.02% | 418 |
|
|
2022
Q1 | $8.43M | Buy |
241,500
+74,800
| +45% | +$2.03M | 0.01% | 490 |
|
|
2021
Q4 | $5.14M | Buy |
+166,700
| New | +$4.42M | ﹤0.01% | 612 |
|
|
2021
Q3 | – | Sell |
-23,750
| Closed | -$788K | – | 1261 |
|
|
2021
Q2 | $788K | Buy |
23,750
+4,525
| +24% | +$145K | ﹤0.01% | 955 |
|
|
2021
Q1 | $1.29M | Sell |
19,225
-21,300
| -53% | -$770K | ﹤0.01% | 816 |
|
|
2020
Q4 | $2.42M | Sell |
40,525
-12,800
| -24% | -$540K | ﹤0.01% | 695 |
|
|
2020
Q3 | $2.13M | Buy |
53,325
+29,025
| +119% | +$1.38M | ﹤0.01% | 572 |
|
|
2020
Q2 | $1.59M | Buy |
24,300
+11,450
| +89% | +$656K | ﹤0.01% | 608 |
|
|
2020
Q1 | $827K | Sell |
12,850
-8,025
| -38% | -$591K | ﹤0.01% | 667 |
|
|
2019
Q4 | $2.22M | Buy |
+20,875
| New | +$1.65M | 0.01% | 502 |
|
|
2019
Q1 | – | Sell |
-4,575
| Closed | -$643K | – | 852 |
|
|
2018
Q4 | $643K | Buy |
+4,575
| New | +$438K | ﹤0.01% | 547 |
|
Other funds holding RXD
AWA
IMC Chicago's RXD Position: Q1 2026 in Review
IMC Chicago opened a new position in ProShares UltraShort Health Care (RXD) in Q1 2026: 10,291 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #4972 among its holdings. This is a return to the name: IMC Chicago previously reported a position in RXD as recently as Q2 2025.
IMC Chicago first reported a position in RXD in Q2 2023 and has held it in 4 quarters since. The position peaked at $271K in Q2 2025. 5 funds tracked by Wall St. Rank hold RXD as of Q1 2026.
- IMC Chicago held 10,291 shares of ProShares UltraShort Health Care worth $209K as of Q1 2026.
- ProShares UltraShort Health Care was a new IMC Chicago position in Q1 2026.
- ProShares UltraShort Health Care made up ﹤0.01% of IMC Chicago's portfolio in Q1 2026, its #4972 holding.
- IMC Chicago first reported a position in ProShares UltraShort Health Care in Q2 2023 and has held it in 4 quarters since.
- IMC Chicago's ProShares UltraShort Health Care position peaked at $271K in Q2 2025.
- 5 funds tracked by Wall St. Rank held ProShares UltraShort Health Care as of Q1 2026.
Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.